BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute for Bioengineering of Catalonia
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220304T100000
DTEND;TZID=Europe/Madrid:20220304T120000
DTSTAMP:20220429T090715Z
CREATED:20220429T090715Z
LAST-MODIFIED:20220429T090715Z
UID:93984-1646388000-1646395200@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Stefano Pulchino
DESCRIPTION:Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS\n\n\n\nStefano Pulchino\, University of Cambridge \n\n\n\nThere are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel strategies capable of modifying disease progression\, abrogating persistent CNS inflammation\, and support degenerating axons in people with persistent inflammation of the\, such as that occurring in progressive MS. \n\n\n\nUnderstanding why regeneration fails in the progressive MS brain and developing new regenerative approaches is a key priority for the Pluchino Lab. \n\n\n\nIn particular\, we aim to elucidate how the immune system\, in particular its cells called myeloid cells\, affects brain structure and function under normal healthy conditions and in disease. \n\n\n\nOur objective is to find how myeloid cells communicate with the central nervous system and affect tissue healing and functional recovery by stimulating mechanisms of brain plasticity mechanisms such as the generation of new nerve cells and the reduction of scar formation. \n\n\n\nApplying combination of state-of-the-art omic technologies\, and molecular approaches to study murine and human disease models of inflammation and neurodegeneration\, we aim to develop experimental molecular medicines\, including those with stem cells and gene therapy vectors\, which slow down the accumulation of irreversible disabilities and improve functional recovery after progressive multiple sclerosis\, stroke and traumatic injuries. \n\n\n\nBy understanding the mechanisms of intercellular (neuro-immune) signalling\, diseases of the brain and spinal cord may be treated more effectively\, and significant neuroprotection may be achieved with new tailored molecular therapeutics. \n\n\n\n\n\n\n\nI have received my MD and PhD degrees at the University of Siena\, Italy\, and additional training at Cambridge University\, UK. I am currently Professor of Regenerative Neuroimmunology and Honorary Consultant in Neurology\, within the Department of Clinical Neurosciences at Cambridge University. \n\n\n\nI have a strong interest in Regenerative Neuroimmunology\, and my research over the last 20 years has recalibrated the classical view that cellular grafts only function through structural cell replacement and opened up a new therapeutic avenue by which to use exogenously delivered stem cells\, or even stem cell-derived acellular therapies that include extracellular vesicles and exosomes. \n\n\n\nThe Pluchino team studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells\, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying. Such mechanisms may be harnessed and used to modulate disease states in an effort to repair and/or regenerate critical components of the nervous system. \n\n\n\nI am recipient of numerous national and international awards\, among which the Italian Multiple Sclerosis Foundation (FISM) Rita Levi-Montalcini prize for outstanding research in MS (2007)\, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 European Research Council (ERC) Starting Independent Award. \n\n\n\nMy laboratory research on Regenerative Neuroimmunology is documented in >230 publications in international journals\, including many recent articles in highly prestigious journals\, such as Nature\, Cell\, Cell Stem Cell\, Nat Cell Biol\, Nat Chem Biol\, PNAS\, PLoS Med\, Brain\, Ann Neurol\, and J Neurosci\, as well as invited review articles in Nat Rev Neurosci\, Physiol Reviews\, Trends in Mol Med and Trends Immunol. My publications have to date received >14.000 citations (ISI-WOK)\, having a Hirsch Factor of 52. \n\n\n\n\n\n\n\nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-stefano-pulchino/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220304T100000
DTEND;TZID=Europe/Madrid:20220304T120000
DTSTAMP:20220429T090715Z
CREATED:20220429T090715Z
LAST-MODIFIED:20220429T090715Z
UID:93985-1646388000-1646395200@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Stefano Pulchino
DESCRIPTION:Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS\n\n\n\nStefano Pulchino\, University of Cambridge \n\n\n\nThere are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel strategies capable of modifying disease progression\, abrogating persistent CNS inflammation\, and support degenerating axons in people with persistent inflammation of the\, such as that occurring in progressive MS. \n\n\n\nUnderstanding why regeneration fails in the progressive MS brain and developing new regenerative approaches is a key priority for the Pluchino Lab. \n\n\n\nIn particular\, we aim to elucidate how the immune system\, in particular its cells called myeloid cells\, affects brain structure and function under normal healthy conditions and in disease. \n\n\n\nOur objective is to find how myeloid cells communicate with the central nervous system and affect tissue healing and functional recovery by stimulating mechanisms of brain plasticity mechanisms such as the generation of new nerve cells and the reduction of scar formation. \n\n\n\nApplying combination of state-of-the-art omic technologies\, and molecular approaches to study murine and human disease models of inflammation and neurodegeneration\, we aim to develop experimental molecular medicines\, including those with stem cells and gene therapy vectors\, which slow down the accumulation of irreversible disabilities and improve functional recovery after progressive multiple sclerosis\, stroke and traumatic injuries. \n\n\n\nBy understanding the mechanisms of intercellular (neuro-immune) signalling\, diseases of the brain and spinal cord may be treated more effectively\, and significant neuroprotection may be achieved with new tailored molecular therapeutics. \n\n\n\n\n\n\n\nI have received my MD and PhD degrees at the University of Siena\, Italy\, and additional training at Cambridge University\, UK. I am currently Professor of Regenerative Neuroimmunology and Honorary Consultant in Neurology\, within the Department of Clinical Neurosciences at Cambridge University. \n\n\n\nI have a strong interest in Regenerative Neuroimmunology\, and my research over the last 20 years has recalibrated the classical view that cellular grafts only function through structural cell replacement and opened up a new therapeutic avenue by which to use exogenously delivered stem cells\, or even stem cell-derived acellular therapies that include extracellular vesicles and exosomes. \n\n\n\nThe Pluchino team studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells\, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying. Such mechanisms may be harnessed and used to modulate disease states in an effort to repair and/or regenerate critical components of the nervous system. \n\n\n\nI am recipient of numerous national and international awards\, among which the Italian Multiple Sclerosis Foundation (FISM) Rita Levi-Montalcini prize for outstanding research in MS (2007)\, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 European Research Council (ERC) Starting Independent Award. \n\n\n\nMy laboratory research on Regenerative Neuroimmunology is documented in >230 publications in international journals\, including many recent articles in highly prestigious journals\, such as Nature\, Cell\, Cell Stem Cell\, Nat Cell Biol\, Nat Chem Biol\, PNAS\, PLoS Med\, Brain\, Ann Neurol\, and J Neurosci\, as well as invited review articles in Nat Rev Neurosci\, Physiol Reviews\, Trends in Mol Med and Trends Immunol. My publications have to date received >14.000 citations (ISI-WOK)\, having a Hirsch Factor of 52. \n\n\n\n\n\n\n\nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-stefano-pulchino/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220304T100000
DTEND;TZID=Europe/Madrid:20220304T120000
DTSTAMP:20220222T141809Z
CREATED:20220222T141809Z
LAST-MODIFIED:20220222T141809Z
UID:96531-1646388000-1646395200@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Stefano Pulchino
DESCRIPTION:Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS\nStefano Pulchino\, University of Cambridge \nThere are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel strategies capable of modifying disease progression\, abrogating persistent CNS inflammation\, and support degenerating axons in people with persistent inflammation of the\, such as that occurring in progressive MS. \nUnderstanding why regeneration fails in the progressive MS brain and developing new regenerative approaches is a key priority for the Pluchino Lab. \nIn particular\, we aim to elucidate how the immune system\, in particular its cells called myeloid cells\, affects brain structure and function under normal healthy conditions and in disease. \nOur objective is to find how myeloid cells communicate with the central nervous system and affect tissue healing and functional recovery by stimulating mechanisms of brain plasticity mechanisms such as the generation of new nerve cells and the reduction of scar formation. \nApplying combination of state-of-the-art omic technologies\, and molecular approaches to study murine and human disease models of inflammation and neurodegeneration\, we aim to develop experimental molecular medicines\, including those with stem cells and gene therapy vectors\, which slow down the accumulation of irreversible disabilities and improve functional recovery after progressive multiple sclerosis\, stroke and traumatic injuries. \nBy understanding the mechanisms of intercellular (neuro-immune) signalling\, diseases of the brain and spinal cord may be treated more effectively\, and significant neuroprotection may be achieved with new tailored molecular therapeutics. \n\nI have received my MD and PhD degrees at the University of Siena\, Italy\, and additional training at Cambridge University\, UK. I am currently Professor of Regenerative Neuroimmunology and Honorary Consultant in Neurology\, within the Department of Clinical Neurosciences at Cambridge University. \nI have a strong interest in Regenerative Neuroimmunology\, and my research over the last 20 years has recalibrated the classical view that cellular grafts only function through structural cell replacement and opened up a new therapeutic avenue by which to use exogenously delivered stem cells\, or even stem cell-derived acellular therapies that include extracellular vesicles and exosomes. \nThe Pluchino team studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells\, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying. Such mechanisms may be harnessed and used to modulate disease states in an effort to repair and/or regenerate critical components of the nervous system. \nI am recipient of numerous national and international awards\, among which the Italian Multiple Sclerosis Foundation (FISM) Rita Levi-Montalcini prize for outstanding research in MS (2007)\, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 European Research Council (ERC) Starting Independent Award. \nMy laboratory research on Regenerative Neuroimmunology is documented in >230 publications in international journals\, including many recent articles in highly prestigious journals\, such as Nature\, Cell\, Cell Stem Cell\, Nat Cell Biol\, Nat Chem Biol\, PNAS\, PLoS Med\, Brain\, Ann Neurol\, and J Neurosci\, as well as invited review articles in Nat Rev Neurosci\, Physiol Reviews\, Trends in Mol Med and Trends Immunol. My publications have to date received >14.000 citations (ISI-WOK)\, having a Hirsch Factor of 52. \n\nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-stefano-pulchino-3/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220304T100000
DTEND;TZID=Europe/Madrid:20220304T120000
DTSTAMP:20220222T141809Z
CREATED:20220222T141809Z
LAST-MODIFIED:20220222T141809Z
UID:96534-1646388000-1646395200@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Stefano Pulchino
DESCRIPTION:Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS\nStefano Pulchino\, University of Cambridge \nThere are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel strategies capable of modifying disease progression\, abrogating persistent CNS inflammation\, and support degenerating axons in people with persistent inflammation of the\, such as that occurring in progressive MS. \nUnderstanding why regeneration fails in the progressive MS brain and developing new regenerative approaches is a key priority for the Pluchino Lab. \nIn particular\, we aim to elucidate how the immune system\, in particular its cells called myeloid cells\, affects brain structure and function under normal healthy conditions and in disease. \nOur objective is to find how myeloid cells communicate with the central nervous system and affect tissue healing and functional recovery by stimulating mechanisms of brain plasticity mechanisms such as the generation of new nerve cells and the reduction of scar formation. \nApplying combination of state-of-the-art omic technologies\, and molecular approaches to study murine and human disease models of inflammation and neurodegeneration\, we aim to develop experimental molecular medicines\, including those with stem cells and gene therapy vectors\, which slow down the accumulation of irreversible disabilities and improve functional recovery after progressive multiple sclerosis\, stroke and traumatic injuries. \nBy understanding the mechanisms of intercellular (neuro-immune) signalling\, diseases of the brain and spinal cord may be treated more effectively\, and significant neuroprotection may be achieved with new tailored molecular therapeutics. \n\nI have received my MD and PhD degrees at the University of Siena\, Italy\, and additional training at Cambridge University\, UK. I am currently Professor of Regenerative Neuroimmunology and Honorary Consultant in Neurology\, within the Department of Clinical Neurosciences at Cambridge University. \nI have a strong interest in Regenerative Neuroimmunology\, and my research over the last 20 years has recalibrated the classical view that cellular grafts only function through structural cell replacement and opened up a new therapeutic avenue by which to use exogenously delivered stem cells\, or even stem cell-derived acellular therapies that include extracellular vesicles and exosomes. \nThe Pluchino team studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells\, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying. Such mechanisms may be harnessed and used to modulate disease states in an effort to repair and/or regenerate critical components of the nervous system. \nI am recipient of numerous national and international awards\, among which the Italian Multiple Sclerosis Foundation (FISM) Rita Levi-Montalcini prize for outstanding research in MS (2007)\, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 European Research Council (ERC) Starting Independent Award. \nMy laboratory research on Regenerative Neuroimmunology is documented in >230 publications in international journals\, including many recent articles in highly prestigious journals\, such as Nature\, Cell\, Cell Stem Cell\, Nat Cell Biol\, Nat Chem Biol\, PNAS\, PLoS Med\, Brain\, Ann Neurol\, and J Neurosci\, as well as invited review articles in Nat Rev Neurosci\, Physiol Reviews\, Trends in Mol Med and Trends Immunol. My publications have to date received >14.000 citations (ISI-WOK)\, having a Hirsch Factor of 52. \n\nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-stefano-pulchino-4/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220304T100000
DTEND;TZID=Europe/Madrid:20220304T120000
DTSTAMP:20220222T141809Z
CREATED:20220222T141809Z
LAST-MODIFIED:20220222T141809Z
UID:90595-1646388000-1646395200@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Stefano Pulchino
DESCRIPTION:Regenerative Neuroimmunology – new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS\nStefano Pulchino\, University of Cambridge \nThere are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel strategies capable of modifying disease progression\, abrogating persistent CNS inflammation\, and support degenerating axons in people with persistent inflammation of the\, such as that occurring in progressive MS. \nUnderstanding why regeneration fails in the progressive MS brain and developing new regenerative approaches is a key priority for the Pluchino Lab. \nIn particular\, we aim to elucidate how the immune system\, in particular its cells called myeloid cells\, affects brain structure and function under normal healthy conditions and in disease. \nOur objective is to find how myeloid cells communicate with the central nervous system and affect tissue healing and functional recovery by stimulating mechanisms of brain plasticity mechanisms such as the generation of new nerve cells and the reduction of scar formation. \nApplying combination of state-of-the-art omic technologies\, and molecular approaches to study murine and human disease models of inflammation and neurodegeneration\, we aim to develop experimental molecular medicines\, including those with stem cells and gene therapy vectors\, which slow down the accumulation of irreversible disabilities and improve functional recovery after progressive multiple sclerosis\, stroke and traumatic injuries. \nBy understanding the mechanisms of intercellular (neuro-immune) signalling\, diseases of the brain and spinal cord may be treated more effectively\, and significant neuroprotection may be achieved with new tailored molecular therapeutics. \n\nI have received my MD and PhD degrees at the University of Siena\, Italy\, and additional training at Cambridge University\, UK. I am currently Professor of Regenerative Neuroimmunology and Honorary Consultant in Neurology\, within the Department of Clinical Neurosciences at Cambridge University. \nI have a strong interest in Regenerative Neuroimmunology\, and my research over the last 20 years has recalibrated the classical view that cellular grafts only function through structural cell replacement and opened up a new therapeutic avenue by which to use exogenously delivered stem cells\, or even stem cell-derived acellular therapies that include extracellular vesicles and exosomes. \nThe Pluchino team studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells\, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying. Such mechanisms may be harnessed and used to modulate disease states in an effort to repair and/or regenerate critical components of the nervous system. \nI am recipient of numerous national and international awards\, among which the Italian Multiple Sclerosis Foundation (FISM) Rita Levi-Montalcini prize for outstanding research in MS (2007)\, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 European Research Council (ERC) Starting Independent Award. \nMy laboratory research on Regenerative Neuroimmunology is documented in >230 publications in international journals\, including many recent articles in highly prestigious journals\, such as Nature\, Cell\, Cell Stem Cell\, Nat Cell Biol\, Nat Chem Biol\, PNAS\, PLoS Med\, Brain\, Ann Neurol\, and J Neurosci\, as well as invited review articles in Nat Rev Neurosci\, Physiol Reviews\, Trends in Mol Med and Trends Immunol. My publications have to date received >14.000 citations (ISI-WOK)\, having a Hirsch Factor of 52. \n\nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-stefano-pulchino-2/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220228T000000
DTEND;TZID=Europe/Madrid:20220228T130000
DTSTAMP:20220429T070900Z
CREATED:20220429T070900Z
LAST-MODIFIED:20220429T070900Z
UID:93911-1646006400-1646053200@ibecbarcelona.eu
SUMMARY:Nano Rare Diseases Day 2022
DESCRIPTION:Nano Rare Diseases Day es un evento organizado en el marco del Día Mundial de las Enfermedades Minoritarias donde se darán a conocer las últimas innovaciones en materia de Nanomedicina con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o el desarrollo de nuevas terapias. \n\n\n\nDurante esta jornada\, expertos en Nanomedicina de diferentes campos -investigación\, empresa\, práctica clínica\, autoridades sanitarias\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la Nanomedicina significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento de las enfermedades minoritarias. \n\n\n\nRegistro a la jornada online\, aquí
URL:https://ibecbarcelona.eu/event/nano-rare-diseases-day-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220228T000000
DTEND;TZID=Europe/Madrid:20220228T130000
DTSTAMP:20220429T070901Z
CREATED:20220429T070900Z
LAST-MODIFIED:20220429T070901Z
UID:93910-1646006400-1646053200@ibecbarcelona.eu
SUMMARY:Nano Rare Diseases Day 2022
DESCRIPTION:Nano Rare Diseases Day es un evento organizado en el marco del Día Mundial de las Enfermedades Minoritarias donde se darán a conocer las últimas innovaciones en materia de Nanomedicina con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o el desarrollo de nuevas terapias. \n\n\n\nDurante esta jornada\, expertos en Nanomedicina de diferentes campos -investigación\, empresa\, práctica clínica\, autoridades sanitarias\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la Nanomedicina significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento de las enfermedades minoritarias. \n\n\n\nRegistro a la jornada online\, aquí
URL:https://ibecbarcelona.eu/event/nano-rare-diseases-day-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220228T000000
DTEND;TZID=Europe/Madrid:20220228T130000
DTSTAMP:20220429T070900Z
CREATED:20220429T070900Z
LAST-MODIFIED:20220429T070900Z
UID:93912-1646006400-1646053200@ibecbarcelona.eu
SUMMARY:Nano Rare Diseases Day 2022
DESCRIPTION:Nano Rare Diseases Day es un evento organizado en el marco del Día Mundial de las Enfermedades Minoritarias donde se darán a conocer las últimas innovaciones en materia de Nanomedicina con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o el desarrollo de nuevas terapias. \n\n\n\nDurante esta jornada\, expertos en Nanomedicina de diferentes campos -investigación\, empresa\, práctica clínica\, autoridades sanitarias\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la Nanomedicina significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento de las enfermedades minoritarias. \n\n\n\nRegistro a la jornada online\, aquí
URL:https://ibecbarcelona.eu/event/nano-rare-diseases-day-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220225T100000
DTEND;TZID=Europe/Madrid:20220225T170000
DTSTAMP:20220427T110926Z
CREATED:20220427T110714Z
LAST-MODIFIED:20220427T110926Z
UID:93904-1645783200-1645808400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Giulia Fornabaio and Shubham Tanwar
DESCRIPTION:Biomechanics of the progression of colorectal carcinomas\n\n\n\nGiulia Fornabaio\, Synthetic morphogenesis group \n\n\n\nAccording to the World Health Organization\, cancer is one of the main causes of death worldwide\, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells from the primary tumour to secondary organs such as the liver\, the lung and the peritoneum. These cells can disseminate either as single isolated cells or as collective clusters\, undergoing a series of molecular and cellular changes commonly known as Epithelial to Mesenchymal Transition (EMT). However\, in 2018\, Jaulin and her team described a novel modality of peritoneal metastatic spread characterized by the presence of large clusters of cancer cells\, which maintain their epithelial properties and display an outward apical polarity. These clusters of cells\, termed tumour spheres with inverted polarity (TSIPs)\, were found in peritoneal effusions of CRCs patients showing early KRAS mutation and hypermethylation of CpG Islands. \n\n\n\nTSIPs originate through a series of morphological changes: the first event is the sprouting of hypermethylated epithelia\, followed by their apical budding\, leading to the formation of rounded spherical clusters of cells called buds\, and the subsequent cleavage of the newly formed spheres. How cell and tissue mechanics drive this process is still unclear. To provide novel insights into this metastatic cascade\, our project aims at deciphering the biomechanical and cellular events regulating the formation of buds in colorectal cancer cell lines. Employing a combination between cellular biology techniques with biophysical methods\, we showed that this process is characterized by over-proliferation and local changes in cell adhesion\, coupled with the formation of cellular vortexes surrounding the buds. Our study demonstrates that buds development in colorectal carcinomas epithelia is governed by morphological transitions occurring entirely at multicellular level\, rather than by single cells aggregation or cell extrusion. \n\n\n\nImaging Functional Organic Bioelectronic Platforms at the Nanoscale\n\n\n\nShubham Tanwar\, Nanoscale Bioelectrical Characterization group \n\n\n\nIn recent years\, many organic bioelectronic platforms have emerged to bridge the signaling gap between biology and technology. Organic bioelectronic platforms based on transistor architecture\, commonly known as Electrolyte-Gated Transistors (EGTs)\, are an excellent tool to selectively sense\, record\, and monitor biological signals and states\, and convert them into measurable electrical signals.1 Biological events happening at the nanoscale are now routinely studied and characterized by a millimeter-sized transistor. However\, it is not well understood how these nanoscale events interact with the transistor’s nanoscale properties leading to a change in their macroscale response. This gap in understanding is purely due to the lack of techniques to image the electrical properties in a liquid environment. Towards this goal\, our group has adapted in-Liquid Scanning Dielectric Microscopy to unravel the inner working of EGTs at the nanoscale.2 Besides apparent topographical changes\, electrical properties\, like conductivity and interfacial capacitance\, and mechanical properties are mapped at the nanoscale in a working transistor in liquid. The vast information extracted has made it possible to correlate the nanoscale processes with the macroscale response\, offering improved understanding and the potential for substantial optimization of bioelectronic devices. \n\n\n\nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-discussions-giulia-fornabaio-and-shubham-tanwar/
LOCATION:IBEC\, floor 11\, Tower i
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220225T100000
DTEND;TZID=Europe/Madrid:20220225T170000
DTSTAMP:20220427T110714Z
CREATED:20220427T110714Z
LAST-MODIFIED:20220427T110714Z
UID:93905-1645783200-1645808400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Giulia Fornabaio and Shubham Tanwar
DESCRIPTION:Biomechanics of the progression of colorectal carcinomas\n\n\n\nGiulia Fornabaio\, Synthetic morphogenesis group \n\n\n\nAccording to the World Health Organization\, cancer is one of the main causes of death worldwide\, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells from the primary tumour to secondary organs such as the liver\, the lung and the peritoneum. These cells can disseminate either as single isolated cells or as collective clusters\, undergoing a series of molecular and cellular changes commonly known as Epithelial to Mesenchymal Transition (EMT). However\, in 2018\, Jaulin and her team described a novel modality of peritoneal metastatic spread characterized by the presence of large clusters of cancer cells\, which maintain their epithelial properties and display an outward apical polarity. These clusters of cells\, termed tumour spheres with inverted polarity (TSIPs)\, were found in peritoneal effusions of CRCs patients showing early KRAS mutation and hypermethylation of CpG Islands. \n\n\n\nTSIPs originate through a series of morphological changes: the first event is the sprouting of hypermethylated epithelia\, followed by their apical budding\, leading to the formation of rounded spherical clusters of cells called buds\, and the subsequent cleavage of the newly formed spheres. How cell and tissue mechanics drive this process is still unclear. To provide novel insights into this metastatic cascade\, our project aims at deciphering the biomechanical and cellular events regulating the formation of buds in colorectal cancer cell lines. Employing a combination between cellular biology techniques with biophysical methods\, we showed that this process is characterized by over-proliferation and local changes in cell adhesion\, coupled with the formation of cellular vortexes surrounding the buds. Our study demonstrates that buds development in colorectal carcinomas epithelia is governed by morphological transitions occurring entirely at multicellular level\, rather than by single cells aggregation or cell extrusion. \n\n\n\nImaging Functional Organic Bioelectronic Platforms at the Nanoscale\n\n\n\nShubham Tanwar\, Nanoscale Bioelectrical Characterization group \n\n\n\nIn recent years\, many organic bioelectronic platforms have emerged to bridge the signaling gap between biology and technology. Organic bioelectronic platforms based on transistor architecture\, commonly known as Electrolyte-Gated Transistors (EGTs)\, are an excellent tool to selectively sense\, record\, and monitor biological signals and states\, and convert them into measurable electrical signals.1 Biological events happening at the nanoscale are now routinely studied and characterized by a millimeter-sized transistor. However\, it is not well understood how these nanoscale events interact with the transistor’s nanoscale properties leading to a change in their macroscale response. This gap in understanding is purely due to the lack of techniques to image the electrical properties in a liquid environment. Towards this goal\, our group has adapted in-Liquid Scanning Dielectric Microscopy to unravel the inner working of EGTs at the nanoscale.2 Besides apparent topographical changes\, electrical properties\, like conductivity and interfacial capacitance\, and mechanical properties are mapped at the nanoscale in a working transistor in liquid. The vast information extracted has made it possible to correlate the nanoscale processes with the macroscale response\, offering improved understanding and the potential for substantial optimization of bioelectronic devices. \n\n\n\nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-discussions-giulia-fornabaio-and-shubham-tanwar/
LOCATION:IBEC\, floor 11\, Tower i
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220225T100000
DTEND;TZID=Europe/Madrid:20220225T170000
DTSTAMP:20220503T142126Z
CREATED:20220427T110714Z
LAST-MODIFIED:20220503T142126Z
UID:93902-1645783200-1645808400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Giulia Fornabaio and Shubham Tanwar
DESCRIPTION:Biomechanics of the progression of colorectal carcinomas\n\n\n\nGiulia Fornabaio\, Synthetic morphogenesis group \n\n\n\nAccording to the World Health Organization\, cancer is one of the main causes of death worldwide\, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells from the primary tumour to secondary organs such as the liver\, the lung and the peritoneum. These cells can disseminate either as single isolated cells or as collective clusters\, undergoing a series of molecular and cellular changes commonly known as Epithelial to Mesenchymal Transition (EMT). However\, in 2018\, Jaulin and her team described a novel modality of peritoneal metastatic spread characterized by the presence of large clusters of cancer cells\, which maintain their epithelial properties and display an outward apical polarity. These clusters of cells\, termed tumour spheres with inverted polarity (TSIPs)\, were found in peritoneal effusions of CRCs patients showing early KRAS mutation and hypermethylation of CpG Islands. \n\n\n\nTSIPs originate through a series of morphological changes: the first event is the sprouting of hypermethylated epithelia\, followed by their apical budding\, leading to the formation of rounded spherical clusters of cells called buds\, and the subsequent cleavage of the newly formed spheres. How cell and tissue mechanics drive this process is still unclear. To provide novel insights into this metastatic cascade\, our project aims at deciphering the biomechanical and cellular events regulating the formation of buds in colorectal cancer cell lines. Employing a combination between cellular biology techniques with biophysical methods\, we showed that this process is characterized by over-proliferation and local changes in cell adhesion\, coupled with the formation of cellular vortexes surrounding the buds. Our study demonstrates that buds development in colorectal carcinomas epithelia is governed by morphological transitions occurring entirely at multicellular level\, rather than by single cells aggregation or cell extrusion. \n\n\n\nImaging Functional Organic Bioelectronic Platforms at the Nanoscale\n\n\n\nShubham Tanwar\, Nanoscale Bioelectrical Characterization group \n\n\n\nIn recent years\, many organic bioelectronic platforms have emerged to bridge the signaling gap between biology and technology. Organic bioelectronic platforms based on transistor architecture\, commonly known as Electrolyte-Gated Transistors (EGTs)\, are an excellent tool to selectively sense\, record\, and monitor biological signals and states\, and convert them into measurable electrical signals.1 Biological events happening at the nanoscale are now routinely studied and characterized by a millimeter-sized transistor. However\, it is not well understood how these nanoscale events interact with the transistor’s nanoscale properties leading to a change in their macroscale response. This gap in understanding is purely due to the lack of techniques to image the electrical properties in a liquid environment. Towards this goal\, our group has adapted in-Liquid Scanning Dielectric Microscopy to unravel the inner working of EGTs at the nanoscale.2 Besides apparent topographical changes\, electrical properties\, like conductivity and interfacial capacitance\, and mechanical properties are mapped at the nanoscale in a working transistor in liquid. The vast information extracted has made it possible to correlate the nanoscale processes with the macroscale response\, offering improved understanding and the potential for substantial optimization of bioelectronic devices. \n\n\n\nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-discussions-giulia-fornabaio-and-shubham-tanwar/
LOCATION:IBEC\, floor 11\, Tower i\, Baldiri Reixac 4-8\, Barcelona\, 08028\, Spain
CATEGORIES:PhD Discussions Session
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220225T100000
DTEND;TZID=Europe/Madrid:20220225T170000
DTSTAMP:20220218T094610Z
CREATED:20220218T094610Z
LAST-MODIFIED:20220218T094610Z
UID:90539-1645783200-1645808400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Giulia Fornabaio and Shubham Tanwar
DESCRIPTION:Biomechanics of the progression of colorectal carcinomas\nGiulia Fornabaio\, Synthetic morphogenesis group \nAccording to the World Health Organization\, cancer is one of the main causes of death worldwide\, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells from the primary tumour to secondary organs such as the liver\, the lung and the peritoneum. These cells can disseminate either as single isolated cells or as collective clusters\, undergoing a series of molecular and cellular changes commonly known as Epithelial to Mesenchymal Transition (EMT). However\, in 2018\, Jaulin and her team described a novel modality of peritoneal metastatic spread characterized by the presence of large clusters of cancer cells\, which maintain their epithelial properties and display an outward apical polarity. These clusters of cells\, termed tumour spheres with inverted polarity (TSIPs)\, were found in peritoneal effusions of CRCs patients showing early KRAS mutation and hypermethylation of CpG Islands. \nTSIPs originate through a series of morphological changes: the first event is the sprouting of hypermethylated epithelia\, followed by their apical budding\, leading to the formation of rounded spherical clusters of cells called buds\, and the subsequent cleavage of the newly formed spheres. How cell and tissue mechanics drive this process is still unclear. To provide novel insights into this metastatic cascade\, our project aims at deciphering the biomechanical and cellular events regulating the formation of buds in colorectal cancer cell lines. Employing a combination between cellular biology techniques with biophysical methods\, we showed that this process is characterized by over-proliferation and local changes in cell adhesion\, coupled with the formation of cellular vortexes surrounding the buds. Our study demonstrates that buds development in colorectal carcinomas epithelia is governed by morphological transitions occurring entirely at multicellular level\, rather than by single cells aggregation or cell extrusion. \nImaging Functional Organic Bioelectronic Platforms at the Nanoscale\nShubham Tanwar\, Nanoscale Bioelectrical Characterization group \nIn recent years\, many organic bioelectronic platforms have emerged to bridge the signaling gap between biology and technology. Organic bioelectronic platforms based on transistor architecture\, commonly known as Electrolyte-Gated Transistors (EGTs)\, are an excellent tool to selectively sense\, record\, and monitor biological signals and states\, and convert them into measurable electrical signals.1 Biological events happening at the nanoscale are now routinely studied and characterized by a millimeter-sized transistor. However\, it is not well understood how these nanoscale events interact with the transistor’s nanoscale properties leading to a change in their macroscale response. This gap in understanding is purely due to the lack of techniques to image the electrical properties in a liquid environment. Towards this goal\, our group has adapted in-Liquid Scanning Dielectric Microscopy to unravel the inner working of EGTs at the nanoscale.2 Besides apparent topographical changes\, electrical properties\, like conductivity and interfacial capacitance\, and mechanical properties are mapped at the nanoscale in a working transistor in liquid. The vast information extracted has made it possible to correlate the nanoscale processes with the macroscale response\, offering improved understanding and the potential for substantial optimization of bioelectronic devices. \nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-discussions-giulia-fornabaio-and-shubham-tanwar-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220225T100000
DTEND;TZID=Europe/Madrid:20220225T170000
DTSTAMP:20220218T094610Z
CREATED:20220218T094610Z
LAST-MODIFIED:20220218T094610Z
UID:96527-1645783200-1645808400@ibecbarcelona.eu
SUMMARY:PhD Discussions: Giulia Fornabaio and Shubham Tanwar
DESCRIPTION:Biomechanics of the progression of colorectal carcinomas\nGiulia Fornabaio\, Synthetic morphogenesis group \nAccording to the World Health Organization\, cancer is one of the main causes of death worldwide\, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells from the primary tumour to secondary organs such as the liver\, the lung and the peritoneum. These cells can disseminate either as single isolated cells or as collective clusters\, undergoing a series of molecular and cellular changes commonly known as Epithelial to Mesenchymal Transition (EMT). However\, in 2018\, Jaulin and her team described a novel modality of peritoneal metastatic spread characterized by the presence of large clusters of cancer cells\, which maintain their epithelial properties and display an outward apical polarity. These clusters of cells\, termed tumour spheres with inverted polarity (TSIPs)\, were found in peritoneal effusions of CRCs patients showing early KRAS mutation and hypermethylation of CpG Islands. \nTSIPs originate through a series of morphological changes: the first event is the sprouting of hypermethylated epithelia\, followed by their apical budding\, leading to the formation of rounded spherical clusters of cells called buds\, and the subsequent cleavage of the newly formed spheres. How cell and tissue mechanics drive this process is still unclear. To provide novel insights into this metastatic cascade\, our project aims at deciphering the biomechanical and cellular events regulating the formation of buds in colorectal cancer cell lines. Employing a combination between cellular biology techniques with biophysical methods\, we showed that this process is characterized by over-proliferation and local changes in cell adhesion\, coupled with the formation of cellular vortexes surrounding the buds. Our study demonstrates that buds development in colorectal carcinomas epithelia is governed by morphological transitions occurring entirely at multicellular level\, rather than by single cells aggregation or cell extrusion. \nImaging Functional Organic Bioelectronic Platforms at the Nanoscale\nShubham Tanwar\, Nanoscale Bioelectrical Characterization group \nIn recent years\, many organic bioelectronic platforms have emerged to bridge the signaling gap between biology and technology. Organic bioelectronic platforms based on transistor architecture\, commonly known as Electrolyte-Gated Transistors (EGTs)\, are an excellent tool to selectively sense\, record\, and monitor biological signals and states\, and convert them into measurable electrical signals.1 Biological events happening at the nanoscale are now routinely studied and characterized by a millimeter-sized transistor. However\, it is not well understood how these nanoscale events interact with the transistor’s nanoscale properties leading to a change in their macroscale response. This gap in understanding is purely due to the lack of techniques to image the electrical properties in a liquid environment. Towards this goal\, our group has adapted in-Liquid Scanning Dielectric Microscopy to unravel the inner working of EGTs at the nanoscale.2 Besides apparent topographical changes\, electrical properties\, like conductivity and interfacial capacitance\, and mechanical properties are mapped at the nanoscale in a working transistor in liquid. The vast information extracted has made it possible to correlate the nanoscale processes with the macroscale response\, offering improved understanding and the potential for substantial optimization of bioelectronic devices. \nThis PhD Discussion session will be held at Tower I\, 11th floor Baobab room\, there will be 30 avialable seats\, the free spots will be assigned on a first come first served basis.
URL:https://ibecbarcelona.eu/event/phd-discussions-giulia-fornabaio-and-shubham-tanwar-2/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220204T100000
DTEND;TZID=Europe/Madrid:20220204T130000
DTSTAMP:20220427T085707Z
CREATED:20220427T085707Z
LAST-MODIFIED:20220427T085707Z
UID:93900-1643968800-1643979600@ibecbarcelona.eu
SUMMARY:Nanodía mundial contra el cáncer – 2022
DESCRIPTION:El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las últimas innovaciones en materia de NANOMEDICINA contra el CÁNCER\, con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o la radioterapia con nanopartículas. \n\n\n\nUn año más\, expertos en NANOMEDICINA de diferentes campos -investigadores\, empresarios\, médicos oncólogos\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la NANOMEDICINA significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento del cáncer y como podemos contribuir en la misión Europea contra el cáncer. \n\n\n\nIniciado bajo el nombre de NANO WORLD CANCER DAY\, NANOMED Spain organiza la edición de este año de manera virtual con la colaboración del VHIR (Vall d’Hebron Instituto de Investigación) y el VHIO (Vall d’Hebron Instituto de Oncología).  \n\n\n\nMás información y registro aquí.
URL:https://ibecbarcelona.eu/event/nanodia-mundial-contra-el-cancer-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220204T100000
DTEND;TZID=Europe/Madrid:20220204T130000
DTSTAMP:20220427T085707Z
CREATED:20220427T085707Z
LAST-MODIFIED:20220427T085707Z
UID:93901-1643968800-1643979600@ibecbarcelona.eu
SUMMARY:Nanodía mundial contra el cáncer – 2022
DESCRIPTION:El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las últimas innovaciones en materia de NANOMEDICINA contra el CÁNCER\, con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o la radioterapia con nanopartículas. \n\n\n\nUn año más\, expertos en NANOMEDICINA de diferentes campos -investigadores\, empresarios\, médicos oncólogos\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la NANOMEDICINA significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento del cáncer y como podemos contribuir en la misión Europea contra el cáncer. \n\n\n\nIniciado bajo el nombre de NANO WORLD CANCER DAY\, NANOMED Spain organiza la edición de este año de manera virtual con la colaboración del VHIR (Vall d’Hebron Instituto de Investigación) y el VHIO (Vall d’Hebron Instituto de Oncología).  \n\n\n\nMás información y registro aquí.
URL:https://ibecbarcelona.eu/event/nanodia-mundial-contra-el-cancer-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220204T100000
DTEND;TZID=Europe/Madrid:20220204T130000
DTSTAMP:20220427T085709Z
CREATED:20220427T085707Z
LAST-MODIFIED:20220427T085709Z
UID:93899-1643968800-1643979600@ibecbarcelona.eu
SUMMARY:Nanodía mundial contra el cáncer – 2022
DESCRIPTION:El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las últimas innovaciones en materia de NANOMEDICINA contra el CÁNCER\, con temas que van desde el diagnóstico precoz\, la liberación controlada de fármacos o la radioterapia con nanopartículas. \n\n\n\nUn año más\, expertos en NANOMEDICINA de diferentes campos -investigadores\, empresarios\, médicos oncólogos\, pacientes\, etc.-\,  expondrán los últimos avances y nos darán la oportunidad de descubrir el generador de progreso que la NANOMEDICINA significa para la salud como creador de nuevas oportunidades en el diagnóstico y el tratamiento del cáncer y como podemos contribuir en la misión Europea contra el cáncer. \n\n\n\nIniciado bajo el nombre de NANO WORLD CANCER DAY\, NANOMED Spain organiza la edición de este año de manera virtual con la colaboración del VHIR (Vall d’Hebron Instituto de Investigación) y el VHIO (Vall d’Hebron Instituto de Oncología).  \n\n\n\nMás información y registro aquí.
URL:https://ibecbarcelona.eu/event/nanodia-mundial-contra-el-cancer-2022/
CATEGORIES:Joint seminar / workshop / symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220201T100000
DTEND;TZID=Europe/Madrid:20220201T120000
DTSTAMP:20220427T085100Z
CREATED:20220427T085100Z
LAST-MODIFIED:20220427T085100Z
UID:93897-1643709600-1643716800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Lucía Selfa Aspiroz
DESCRIPTION:Engineering human pluripotent stem cells to understand kidney development and disease\n\n\n\nLucía Selfa Aspiroz\, Pluripotency for organ regeneration group \n\n\n\nThis thesis defence will start at 10AM. If you wisth to attend to this PhD thesis defence\, you can join here via zoom.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-lucia-selfa-aspiroz/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220201T100000
DTEND;TZID=Europe/Madrid:20220201T120000
DTSTAMP:20220427T085100Z
CREATED:20220427T085100Z
LAST-MODIFIED:20220427T085100Z
UID:93898-1643709600-1643716800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Lucía Selfa Aspiroz
DESCRIPTION:Engineering human pluripotent stem cells to understand kidney development and disease\n\n\n\nLucía Selfa Aspiroz\, Pluripotency for organ regeneration group \n\n\n\nThis thesis defence will start at 10AM. If you wisth to attend to this PhD thesis defence\, you can join here via zoom.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-lucia-selfa-aspiroz/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220201T100000
DTEND;TZID=Europe/Madrid:20220201T120000
DTSTAMP:20220427T085101Z
CREATED:20220427T085100Z
LAST-MODIFIED:20220427T085101Z
UID:93896-1643709600-1643716800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Lucía Selfa Aspiroz
DESCRIPTION:Engineering human pluripotent stem cells to understand kidney development and disease\n\n\n\nLucía Selfa Aspiroz\, Pluripotency for organ regeneration group \n\n\n\nThis thesis defence will start at 10AM. If you wisth to attend to this PhD thesis defence\, you can join here via zoom.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-lucia-selfa-aspiroz/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220128T110000
DTEND;TZID=Europe/Madrid:20220128T130000
DTSTAMP:20220427T084624Z
CREATED:20220427T084623Z
LAST-MODIFIED:20220427T084624Z
UID:93893-1643367600-1643374800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Andrea García Lizarribar
DESCRIPTION:Development of tunable bioinks to fabricate 3D-printed in vitro models: a special focus on skeletal muscle models with potential applications in metabolic alteration studies\n\n\n\nAndrea García Lizarribar\, Nanobioengineering group \n\n\n\nThis thesis defence will be held online using the Teams App\, you can find the link here. You can find more information here
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-andrea-garcia-lizarribar/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220128T110000
DTEND;TZID=Europe/Madrid:20220128T130000
DTSTAMP:20220427T084623Z
CREATED:20220427T084623Z
LAST-MODIFIED:20220427T084623Z
UID:93894-1643367600-1643374800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Andrea García Lizarribar
DESCRIPTION:Development of tunable bioinks to fabricate 3D-printed in vitro models: a special focus on skeletal muscle models with potential applications in metabolic alteration studies\n\n\n\nAndrea García Lizarribar\, Nanobioengineering group \n\n\n\nThis thesis defence will be held online using the Teams App\, you can find the link here. You can find more information here
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-andrea-garcia-lizarribar/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220128T110000
DTEND;TZID=Europe/Madrid:20220128T130000
DTSTAMP:20220427T084623Z
CREATED:20220427T084623Z
LAST-MODIFIED:20220427T084623Z
UID:93895-1643367600-1643374800@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Andrea García Lizarribar
DESCRIPTION:Development of tunable bioinks to fabricate 3D-printed in vitro models: a special focus on skeletal muscle models with potential applications in metabolic alteration studies\n\n\n\nAndrea García Lizarribar\, Nanobioengineering group \n\n\n\nThis thesis defence will be held online using the Teams App\, you can find the link here. You can find more information here
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-andrea-garcia-lizarribar/
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220127T110000
DTEND;TZID=Europe/Madrid:20220127T140000
DTSTAMP:20220114T095412Z
CREATED:20220114T093409Z
LAST-MODIFIED:20220114T095412Z
UID:89936-1643281200-1643292000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ariadna Marín Llauradó
DESCRIPTION:Mechanical stress in curved epithelia of designed size and shape\nAriadna Marín Llauradó\, Integrative cell and tissue dynamics group \nThe function of organs such as lungs\, kidneys and mammary glands relies on the three-dimensional geometry of their epithelium. How epithelial geometry emerges from mechanical stresses remains poorly understood. To address this question systematically\, here we engineered curved epithelial monolayers of controlled size and shape and mapped their state of stress. We designed pressurized epithelia with spherical\, rectangular and ellipsoidal cross-sections. We developed a computational approach to map the stress tensor these epithelia from the measured pressure and geometry\, without assumptions of material properties.  In epithelia with spherical cross-section spanning more than one order of magnitude in radius\, we show that stress increases with areal strain in a size-independent manner. In epithelia with rectangular and ellipsoidal cross-section we found pronounced stress anisotropies consistent with asymmetric distribution tractions measured at the cell-substrate contact line. Cells tended to align with the direction of maximum principal stress\, but this alignment was non-universal and increased with monolayer anisotropy. Our study establishes how the size and shape of an epithelium depends on luminal pressure and mechanical stress. \nThis thesis defence will take place at Auditori Antoni Caparrós\, located at the Parc Científic de Barcelona\, Tower D with limited capacity\, seats will be assigned on a first come first served basis. The defence will start at 11 AM.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ariadna-marin-llaurado/
LOCATION:Auditori Antoni Caparrós\, PCB\, Tower D\, c/Baldiri Reixac 4-8\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220127T110000
DTEND;TZID=Europe/Madrid:20220127T140000
DTSTAMP:20220114T095350Z
CREATED:20220114T093409Z
LAST-MODIFIED:20220114T095350Z
UID:89934-1643281200-1643292000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ariadna Marín Llauradó
DESCRIPTION:Mechanical stress in curved epithelia of designed size and shape\nAriadna Marín Llauradó\, Integrative cell and tissue dynamics group \nThe function of organs such as lungs\, kidneys and mammary glands relies on the three-dimensional geometry of their epithelium. How epithelial geometry emerges from mechanical stresses remains poorly understood. To address this question systematically\, here we engineered curved epithelial monolayers of controlled size and shape and mapped their state of stress. We designed pressurized epithelia with spherical\, rectangular and ellipsoidal cross-sections. We developed a computational approach to map the stress tensor these epithelia from the measured pressure and geometry\, without assumptions of material properties.  In epithelia with spherical cross-section spanning more than one order of magnitude in radius\, we show that stress increases with areal strain in a size-independent manner. In epithelia with rectangular and ellipsoidal cross-section we found pronounced stress anisotropies consistent with asymmetric distribution tractions measured at the cell-substrate contact line. Cells tended to align with the direction of maximum principal stress\, but this alignment was non-universal and increased with monolayer anisotropy. Our study establishes how the size and shape of an epithelium depends on luminal pressure and mechanical stress. \nThis thesis defence will take place at Auditori Antoni Caparrós\, located at the Parc Científic de Barcelona\, Tower D with limited capacity\, seats will be assigned on a first come first served basis. The defence will start at 11 AM.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ariadna-marin-llaurado/
LOCATION:Auditori Antoni Caparrós\, PCB\, Tower D\, c/Baldiri Reixac 4-8\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220127T110000
DTEND;TZID=Europe/Madrid:20220127T140000
DTSTAMP:20220114T095438Z
CREATED:20220114T093409Z
LAST-MODIFIED:20220114T095438Z
UID:89937-1643281200-1643292000@ibecbarcelona.eu
SUMMARY:PhD Thesis Defence: Ariadna Marín Llauradó
DESCRIPTION:Mechanical stress in curved epithelia of designed size and shape\nAriadna Marín Llauradó\, Integrative cell and tissue dynamics group \nThe function of organs such as lungs\, kidneys and mammary glands relies on the three-dimensional geometry of their epithelium. How epithelial geometry emerges from mechanical stresses remains poorly understood. To address this question systematically\, here we engineered curved epithelial monolayers of controlled size and shape and mapped their state of stress. We designed pressurized epithelia with spherical\, rectangular and ellipsoidal cross-sections. We developed a computational approach to map the stress tensor these epithelia from the measured pressure and geometry\, without assumptions of material properties.  In epithelia with spherical cross-section spanning more than one order of magnitude in radius\, we show that stress increases with areal strain in a size-independent manner. In epithelia with rectangular and ellipsoidal cross-section we found pronounced stress anisotropies consistent with asymmetric distribution tractions measured at the cell-substrate contact line. Cells tended to align with the direction of maximum principal stress\, but this alignment was non-universal and increased with monolayer anisotropy. Our study establishes how the size and shape of an epithelium depends on luminal pressure and mechanical stress. \nThis thesis defence will take place at Auditori Antoni Caparrós\, located at the Parc Científic de Barcelona\, Tower D with limited capacity\, seats will be assigned on a first come first served basis. The defence will start at 11 AM.
URL:https://ibecbarcelona.eu/event/phd-thesis-defence-ariadna-marin-llaurado/
LOCATION:Auditori Antoni Caparrós\, PCB\, Tower D\, c/Baldiri Reixac 4-8\, Barcelona\, Spain
CATEGORIES:PhD Thesis Defence
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220122T040000
DTEND;TZID=Europe/Madrid:20220122T173000
DTSTAMP:20220427T084207Z
CREATED:20220427T084206Z
LAST-MODIFIED:20220427T084207Z
UID:93890-1642824000-1642872600@ibecbarcelona.eu
SUMMARY:Núria Montserrat at "TEDxBarcelona - 8+3 charlas para vivir una vida saludable"
DESCRIPTION:Evento anual TEDxBarcelona 2022\, una jornada única donde personas extraordinarias presentarán sus ideas para vivir una vida en salud. \n\n\n\nEl evento anual consta de diferentes conferencias divididas en dos sesiones durante toda la jornada\, entre ellas\, los asistentes podrán disfrutar de una feria donde algunas empresas de Barcelona presentarán sus productos innovadores.1ª Ponencia: 16:00h – 17:30h \n\n\n\nJosé Cruset (Director de TEDxBarcelona)Chris Anderson (Curator at TED)Nuria Montserrat (ICREA Research Professor)Violeta Moizé (Profesora asociada de la UB en nutrición)Anneke Stolk (Cofundadora de Instagreen)Carlos Gonzalez y Neus Carol Gres (Proyecto AFIN)Feria y vídeos TED: 17:30h – 18:30h \n\n\n\nDan Buettner (How To Live To Be 100+)Jaime Oliver (Teach Every Child About Food)Tim Urban (Inside the mind of master procrastinator)2ª Ponencia: 18:30h – 20:00h \n\n\n\nChris Anderson (Curator at TED)Carol Blázquez (Directora de innovación y sostenibilidad en ECOALF)Lucía Hernández (Consultora para la ONU)Carlos Alcoba (Presidente de SostreCivic)María Hernández-Alcalá (CEO de Futurlife21) \n\n\n\nEntradas aquí
URL:https://ibecbarcelona.eu/event/nuria-montserrat-at-tedxbarcelona-83-charlas-para-vivir-una-vida-saludable/
CATEGORIES:External symposium / conference / congress
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220122T040000
DTEND;TZID=Europe/Madrid:20220122T173000
DTSTAMP:20220427T084206Z
CREATED:20220427T084206Z
LAST-MODIFIED:20220427T084206Z
UID:93892-1642824000-1642872600@ibecbarcelona.eu
SUMMARY:Núria Montserrat at "TEDxBarcelona - 8+3 charlas para vivir una vida saludable"
DESCRIPTION:Evento anual TEDxBarcelona 2022\, una jornada única donde personas extraordinarias presentarán sus ideas para vivir una vida en salud. \n\n\n\nEl evento anual consta de diferentes conferencias divididas en dos sesiones durante toda la jornada\, entre ellas\, los asistentes podrán disfrutar de una feria donde algunas empresas de Barcelona presentarán sus productos innovadores.1ª Ponencia: 16:00h – 17:30h \n\n\n\nJosé Cruset (Director de TEDxBarcelona)Chris Anderson (Curator at TED)Nuria Montserrat (ICREA Research Professor)Violeta Moizé (Profesora asociada de la UB en nutrición)Anneke Stolk (Cofundadora de Instagreen)Carlos Gonzalez y Neus Carol Gres (Proyecto AFIN)Feria y vídeos TED: 17:30h – 18:30h \n\n\n\nDan Buettner (How To Live To Be 100+)Jaime Oliver (Teach Every Child About Food)Tim Urban (Inside the mind of master procrastinator)2ª Ponencia: 18:30h – 20:00h \n\n\n\nChris Anderson (Curator at TED)Carol Blázquez (Directora de innovación y sostenibilidad en ECOALF)Lucía Hernández (Consultora para la ONU)Carlos Alcoba (Presidente de SostreCivic)María Hernández-Alcalá (CEO de Futurlife21) \n\n\n\nEntradas aquí
URL:https://ibecbarcelona.eu/event/nuria-montserrat-at-tedxbarcelona-83-charlas-para-vivir-una-vida-saludable/
CATEGORIES:External symposium / conference / congress
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220122T040000
DTEND;TZID=Europe/Madrid:20220122T173000
DTSTAMP:20220427T084206Z
CREATED:20220427T084206Z
LAST-MODIFIED:20220427T084206Z
UID:93891-1642824000-1642872600@ibecbarcelona.eu
SUMMARY:Núria Montserrat at "TEDxBarcelona - 8+3 charlas para vivir una vida saludable"
DESCRIPTION:Evento anual TEDxBarcelona 2022\, una jornada única donde personas extraordinarias presentarán sus ideas para vivir una vida en salud. \n\n\n\nEl evento anual consta de diferentes conferencias divididas en dos sesiones durante toda la jornada\, entre ellas\, los asistentes podrán disfrutar de una feria donde algunas empresas de Barcelona presentarán sus productos innovadores.1ª Ponencia: 16:00h – 17:30h \n\n\n\nJosé Cruset (Director de TEDxBarcelona)Chris Anderson (Curator at TED)Nuria Montserrat (ICREA Research Professor)Violeta Moizé (Profesora asociada de la UB en nutrición)Anneke Stolk (Cofundadora de Instagreen)Carlos Gonzalez y Neus Carol Gres (Proyecto AFIN)Feria y vídeos TED: 17:30h – 18:30h \n\n\n\nDan Buettner (How To Live To Be 100+)Jaime Oliver (Teach Every Child About Food)Tim Urban (Inside the mind of master procrastinator)2ª Ponencia: 18:30h – 20:00h \n\n\n\nChris Anderson (Curator at TED)Carol Blázquez (Directora de innovación y sostenibilidad en ECOALF)Lucía Hernández (Consultora para la ONU)Carlos Alcoba (Presidente de SostreCivic)María Hernández-Alcalá (CEO de Futurlife21) \n\n\n\nEntradas aquí
URL:https://ibecbarcelona.eu/event/nuria-montserrat-at-tedxbarcelona-83-charlas-para-vivir-una-vida-saludable/
CATEGORIES:External symposium / conference / congress
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220121T100000
DTEND;TZID=Europe/Madrid:20220121T120000
DTSTAMP:20220111T080313Z
CREATED:20210901T151240Z
LAST-MODIFIED:20220111T080313Z
UID:86926-1642759200-1642766400@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Carlos Aleman
DESCRIPTION:Smart and multifunctional artificial materials for bioengineering\nCarlos Aleman\, Universitat Politècnica de Catalunta (UPC) \nThe research of the ” Innovation\, Modeling & Engineering in Materials” group in the field of multifunctional materials. Three\, different examples of multifunctional systems will be presented: 1) Magnetic electroconductive and self-healing PEDOT:alginate hydrogels for sensing\, drug-delivery and energy storage; 2) Self-standing PLA/PEDOT films as artificial muscles\, controlled lactate release and selective ion transport; and 3) Permanently polarized hydroxyapatite a biocatalyst for carbon and nitrogen fixation. \nCarlos Alemán graduated in Chemistry from the University of Barcelona (Spain). He received his Ph.D. from the Polytechnic University of Catalonia (UPC) in 1994\, where he was promoted to the position of Full Professor of Physical Chemistry. He was postdoctoral researcher at the ETH in Zürich (Switzerland) and visiting professor at the Università di Napoli Federico II (Italy)\, University of Twente (Holland) and Universidade Federal do Rio Grande do Sul (Brazil). Since 2003 he is the leader of the ‘‘Innovation\, Modeling & Engineering in Materials’’ (IMEM) group. His main research interests focus on conducting polymers and biopolymers with biomedical and technological (energy) applications. \nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-carlos-aleman/
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220121T100000
DTEND;TZID=Europe/Madrid:20220121T120000
DTSTAMP:20220111T080516Z
CREATED:20210901T151240Z
LAST-MODIFIED:20220111T080516Z
UID:86928-1642759200-1642766400@ibecbarcelona.eu
SUMMARY:Online IBEC Seminar: Carlos Alemán
DESCRIPTION:Smart and multifunctional artificial materials for bioengineering\nCarlos Alemán\, Universitat Politècnica de Catalunta (UPC) \nThe research of the ” Innovation\, Modeling & Engineering in Materials” group in the field of multifunctional materials. Three\, different examples of multifunctional systems will be presented: 1) Magnetic electroconductive and self-healing PEDOT:alginate hydrogels for sensing\, drug-delivery and energy storage; 2) Self-standing PLA/PEDOT films as artificial muscles\, controlled lactate release and selective ion transport; and 3) Permanently polarized hydroxyapatite a biocatalyst for carbon and nitrogen fixation. \nCarlos Alemán graduated in Chemistry from the University of Barcelona (Spain). He received his Ph.D. from the Polytechnic University of Catalonia (UPC) in 1994\, where he was promoted to the position of Full Professor of Physical Chemistry. He was postdoctoral researcher at the ETH in Zürich (Switzerland) and visiting professor at the Università di Napoli Federico II (Italy)\, University of Twente (Holland) and Universidade Federal do Rio Grande do Sul (Brazil). Since 2003 he is the leader of the ‘‘Innovation\, Modeling & Engineering in Materials’’ (IMEM) group. His main research interests focus on conducting polymers and biopolymers with biomedical and technological (energy) applications. \nThis seminar will take place online\, using the go to meeting app
URL:https://ibecbarcelona.eu/event/online-ibec-seminar-carlos-aleman/
CATEGORIES:IBEC Seminar
END:VEVENT
END:VCALENDAR